Healthcare

HB 79 requires hospitals to establish clear financial assistance programs for patients who cannot afford care, including standardized forms and easily accessible information about eligibility and coverage. It mandates that hospitals publicly share details about their financial aid policies and report their program rules to the Department of Health. These requirements directly affect hospitals operating in the state and patients seeking financial help with medical bills. The bill aims to standardize and increase transparency in hospital financial aid offerings.

HB 433 requires health insurance plans to cover mammograms and breast imaging services without cost-sharing (like copays or deductibles) for policyholders. It directly affects women needing preventive breast cancer screenings and the insurance companies providing health coverage. The bill amends Pennsylvania’s 1921 Insurance Company Law to mandate this coverage for mammographic examinations and breast imaging under casualty insurance policies. This policy change ensures these essential preventive services are fully covered at no additional cost to patients.

HB 409 amends Pennsylvania's Patient Test Result Information Act to require healthcare providers to give patients written notice at the time of diagnostic imaging services (like X-rays, MRIs, and ultrasounds) about how to access their results, including online portals or mail (with a possible fee for mailing). It also mandates a follow-up notice within 20 days if a significant abnormality is found, including details like the test date and ordering doctor's name, unless exceptions apply. Exceptions include routine obstetrical ultrasounds, inpatient or emergency care, diagnostic radiographs (X-rays), and patients with chronic conditions who were previously notified. This bill directly affects patients receiving diagnostic imaging and the healthcare facilities performing these services.

HB 33 amends Pennsylvania's Medical Marijuana Act to clarify definitions and strengthen oversight of testing labs and practitioners. It defines key terms like "independent laboratory" (requiring no ties to marijuana businesses) and "approved laboratory" (testing medical marijuana samples under department approval). The bill gives the Department of Health new authority to impose conditions on medical practitioners, such as limiting certifications or requiring supervision, to protect patient safety. These changes directly affect medical marijuana patients, healthcare providers who certify them, and labs testing products for quality and safety. The updates aim to improve accountability in the program through clearer rules for lab accreditation and practitioner oversight.